speb/financial-data huggingface dataset:
Financial ratios for PSH.L — annual report dated 2022-12-31
Total revenue: -1182853477
Net income: -1172083602
Capital expenditures: 0
Operating cash flow: 366040224
Net tangible assets: 9879933721
Owner earnings: -1172083602
Return on net tangible assets (%): -11.863273935823198
Buffett classification: The Gruesome
Stock price: 0.34204819277108434
Shares outstanding: 175030590
Book value: 9879933721
P/B ratio: 0.006059645608948173
Market cap (USD): 59868896.989156626
Debt to equity: 0.2360914448284283
Free cash flow (dilution-adjusted): 366040224
Buyback yield (%): 438.3304172908511
Retained earnings: 4664447181
Receivables turnover: -90.19843116118824
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PSH.L — annual report dated 2023-12-31
Total revenue: 2570527155
Net income: 2486054201
Capital expenditures: 0
Operating cash flow: 1080214814
Net tangible assets: 12062607027
Owner earnings: 2486054201
Return on net tangible assets (%): 20.60959289675449
Buffett classification: The Gruesome
Stock price: 0.44822784810126576
P/E ratio: 0.031557471545084356
Shares outstanding: 175030590
Book value: 12062607027
P/B ratio: 0.006503866413951025
Market cap (USD): 78453584.70759493
Debt to equity: 0.19497570125062152
Effective tax rate (%): 2.580234761318987
COGS to revenue (%): 0
SG&A to revenue (%): 0.6090410665200695
Free cash flow (dilution-adjusted): 1080214814
Buyback yield (%): 254.87188985086954
Retained earnings: 7051720105
Receivables turnover: 170.58354251523423
Capitalized R&D asset: 0
FCF margin (%): 42.02308510528067
Rule of 40 score: 42.02308510528067
Financial ratios for PSH.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 13011230090
Buffett classification: The Gruesome
Stock price: 0.48612500000000003
Shares outstanding: 175030590
Book value: 13011230090
P/B ratio: 0.006539485119792391
Market cap (USD): 85086745.56375
Debt to equity: 0.17836909231077935
Buyback yield (%): 0
Retained earnings: 8118249341
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PSH.L — annual report dated 2024-12-31
Total revenue: 1204848725
Net income: 1173695918
Capital expenditures: 0
Operating cash flow: -1265610592
Net tangible assets: 13011230090
Owner earnings: 1173695918
Return on net tangible assets (%): 9.02063763288656
Buffett classification: The Gruesome
Stock price: 0.48612500000000003
P/E ratio: 0.0724947103068565
Shares outstanding: 175030590
Book value: 13011230090
P/B ratio: 0.006539485119792391
Market cap (USD): 85086745.56375
Debt to equity: 0.17836909231077935
Effective tax rate (%): 1.2688142163078797
COGS to revenue (%): 0
SG&A to revenue (%): 1.086270477648553
Free cash flow (dilution-adjusted): -1265610592
Buyback yield (%): 140.58975015136056
Retained earnings: 8118249341
Receivables turnover: 43.80242636287549
Capitalized R&D asset: 0
FCF margin (%): -105.04311169852465
Revenue growth (%): -53.128340906400574
Rule of 40 score: -158.17145260492524
Financial ratios for PSH.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 14714588587
Buffett classification: The Gruesome
Stock price: 0.5327397260273973
Shares outstanding: 175030590
Book value: 14714588587
P/B ratio: 0.006336959270841875
Market cap (USD): 93245748.5630137
Debt to equity: 0.2147000070250758
Buyback yield (%): 0
Retained earnings: 9976348798
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RDNT — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 30.11
Shares outstanding: 78634236
Market cap (USD): 2367676845.96
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RDNT — annual report dated 2022-12-31
Total revenue: 1430061000
Gross profit: 165715000
Operating income: 49838000
Net income: 33608000
Capital expenditures: 115547000
Operating cash flow: 146417000
Depreciation & amortization: 184724000
Net tangible assets: -450898000
Owner earnings: 102785000
Return on net tangible assets (%): -22.795621182617797
Capex to operating income (%): 231.84517837794453
Buffett classification: The Gruesome
Stock price: 18.83
P/E ratio: 44.05744655677219
Shares outstanding: 78634236
Book value: 491452000
P/B ratio: 3.0128734116047955
Market cap (USD): 1480682663.8799999
Debt to equity: 3.07958457794454
Current ratio: 0.7867278878478241
Quick ratio: 0.7867278878478241
Effective tax rate (%): 21.785473248155647
Interest coverage ratio: 0.980271827855471
COGS to revenue (%): 88.41203277342716
Free cash flow (dilution-adjusted): 3196000
Buyback yield (%): 0
Retained earnings: -82622000
Receivables turnover: 7.716378528878529
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.5334691620102645
FCF margin (%): 0.22348697013623897
Rule of 40 score: 0.22348697013623897
Financial ratios for RDNT — annual report dated 2023-12-31
Total revenue: 1616630000
Gross profit: 221391000
Operating income: 93000000
Net income: 30337000
Capital expenditures: 176517000
Operating cash flow: 220863000
Depreciation & amortization: 189493000
Net tangible assets: -139383000
Owner earnings: 43313000
Return on net tangible assets (%): -31.07480826212666
Capex to operating income (%): 189.80322580645162
Buffett classification: The Gruesome
Stock price: 34.77
P/E ratio: 90.12467896364177
Shares outstanding: 78634236
Book value: 813359000
P/B ratio: 3.3615075086400967
Market cap (USD): 2734112385.7200003
Debt to equity: 1.8332864085846472
Current ratio: 1.324204712745627
Quick ratio: 1.324204712745627
Effective tax rate (%): 21.832002061324403
Interest coverage ratio: 1.442240590543244
COGS to revenue (%): 86.30540074104773
Free cash flow (dilution-adjusted): 17478000
Buyback yield (%): 0
Retained earnings: -79578000
Receivables turnover: 8.551380858930754
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.127791085835418
FCF margin (%): 1.081137922715773
Revenue growth (%): 13.046226699420515
Rule of 40 score: 14.127364622136287
Financial ratios for RDNT — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 69.39
Shares outstanding: 78634236
Market cap (USD): 5456429636.04
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RDNT — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 69.84
Shares outstanding: 78634236
Market cap (USD): 5491815042.240001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RDNT — annual report dated 2024-12-31
Total revenue: 1829664000
Gross profit: 249115000
Operating income: 111277000
Net income: 38836000
Capital expenditures: 187913000
Operating cash flow: 233023000
Depreciation & amortization: 198390000
Net tangible assets: 110294000
Owner earnings: 49313000
Return on net tangible assets (%): 44.71050102453443
Capex to operating income (%): 168.86957772046333
Buffett classification: The Gruesome
Stock price: 69.84
P/E ratio: 141.4104192563601
Shares outstanding: 78634236
Book value: 1133410000
P/B ratio: 4.845391378442047
Market cap (USD): 5491815042.240001
Debt to equity: 1.525364166541675
Current ratio: 2.1247164965646053
Quick ratio: 2.1247164965646053
Effective tax rate (%): 13.432303508537291
Interest coverage ratio: 1.3935929066112287
COGS to revenue (%): 86.38465860398412
Free cash flow (dilution-adjusted): 15120000
Buyback yield (%): 0
Retained earnings: -76785000
Receivables turnover: 8.035767930080372
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.9642989720617687
FCF margin (%): 0.8263812372107666
Revenue growth (%): 13.17765969949834
Rule of 40 score: 14.004040936709107
Financial ratios for RDNT — quarterly report dated 2025-03-31
Total revenue: 471399000
Gross profit: 17919000
Operating income: -17564000
Net income: -29737000
Capital expenditures: 48810000
Operating cash flow: 41481000
Depreciation & amortization: 35483000
Net tangible assets: 100923000
Owner earnings: -43064000
Return on net tangible assets (%): -42.6701544742031
Buffett classification: The Gruesome
Stock price: 49.72
Shares outstanding: 78634236
Book value: 1136517000
P/B ratio: 3.4400666368562898
Market cap (USD): 3909694213.92
Debt to equity: 1.5363219379912487
Current ratio: 2.0100178274986695
Quick ratio: 2.0100178274986695
Interest coverage ratio: -1.018852601659029
COGS to revenue (%): 96.19876155867959
Free cash flow (dilution-adjusted): -35846000
Buyback yield (%): 0
Retained earnings: -114711000
Receivables turnover: 2.005850765067316
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.620446400658456
FCF margin (%): -7.604173958790748
Rule of 40 score: -7.604173958790748
Financial ratios for RDNT — quarterly report dated 2025-06-30
Total revenue: 498230000
Gross profit: 69145000
Operating income: 33152000
Net income: 23034000
Capital expenditures: 52926000
Operating cash flow: 120348000
Depreciation & amortization: 35993000
Net tangible assets: 89722000
Owner earnings: 6101000
Return on net tangible assets (%): 6.799893002830967
Capex to operating income (%): 159.64647683397683
Buffett classification: The Gruesome
Stock price: 56.91
P/E ratio: 48.57031313232612
Shares outstanding: 78634236
Book value: 1179261000
P/B ratio: 3.7948124891436246
Market cap (USD): 4475074370.759999
Debt to equity: 1.5611938324086017
Current ratio: 2.0035865326522764
Quick ratio: 2.0035865326522764
Effective tax rate (%): 3.43757860316928
Interest coverage ratio: 1.9286753156088197
COGS to revenue (%): 86.12187142484395
Free cash flow (dilution-adjusted): 58664000
Buyback yield (%): 0
Retained earnings: -100257000
Receivables turnover: 2.339657196525006
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.1166966904656361
FCF margin (%): 11.774481665094434
Revenue growth (%): 5.691781272340417
Rule of 40 score: 17.466262937434852
Financial ratios for RDNT — quarterly report dated 2025-09-30
Total revenue: 522869000
Gross profit: 72490000
Operating income: 32691000
Net income: 13889000
Capital expenditures: 60410000
Operating cash flow: 52827000
Depreciation & amortization: 39799000
Net tangible assets: 106096000
Owner earnings: -6722000
Return on net tangible assets (%): -6.335771376866234
Capex to operating income (%): 184.79092104860666
Buffett classification: The Gruesome
Stock price: 76.21
P/E ratio: 833.9431012468689
Shares outstanding: 78634236
Book value: 1313959000
P/B ratio: 4.560808309513463
Market cap (USD): 5992715125.559999
Debt to equity: 1.4061397653960284
Current ratio: 1.8746751688078565
Quick ratio: 1.8746751688078565
Effective tax rate (%): 31.49353852224524
Interest coverage ratio: 1.8836646499567848
COGS to revenue (%): 86.13610674949174
Free cash flow (dilution-adjusted): -16659000
Buyback yield (%): 0
Retained earnings: -94840000
Receivables turnover: 2.3456507110493026
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.05783621028584
FCF margin (%): -3.186075288456573
Revenue growth (%): 4.94530638460149
Rule of 40 score: 1.7592310961449167
Financial ratios for RDNT — annual report dated 2025-12-31
Total revenue: 2040210000
Gross profit: 235485000
Operating income: 83358000
Net income: 17047000
Capital expenditures: 211963000
Operating cash flow: 298820000
Depreciation & amortization: 211994000
Net tangible assets: 33719000
Owner earnings: 17078000
Return on net tangible assets (%): 50.648002609804564
Capex to operating income (%): 254.28033302142566
Buffett classification: The Gruesome
Stock price: 71.35
P/E ratio: 329.1225868833226
Shares outstanding: 78634236
Book value: 1355886000
P/B ratio: 4.137923644465685
Market cap (USD): 5610552738.599999
Debt to equity: 1.3709515401737313
Current ratio: 1.7590185475225943
Quick ratio: 1.7590185475225943
Effective tax rate (%): 46.576201071797925
Interest coverage ratio: 1.1923104429791311
COGS to revenue (%): 88.45780581410737
Free cash flow (dilution-adjusted): 30968000
Buyback yield (%): 0
Retained earnings: -95437000
Receivables turnover: 9.58254465522829
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.6280976101897977
FCF margin (%): 1.5178829630283157
Revenue growth (%): 11.507358728159925
Rule of 40 score: 13.02524169118824
Financial ratios for RDNT — quarterly report dated 2025-12-31
Total revenue: 547712000
Gross profit: 75931000
Operating income: 35079000
Net income: 9861000
Capital expenditures: 49817000
Operating cash flow: 84164000
Depreciation & amortization: 100719000
Net tangible assets: 33719000
Owner earnings: 60763000
Return on net tangible assets (%): 180.2040392656959
Capex to operating income (%): 142.013740414493
Buffett classification: The Gruesome
Stock price: 71.35
P/E ratio: 329.1225868833226
Shares outstanding: 78634236
Book value: 1355886000
P/B ratio: 4.137923644465685
Market cap (USD): 5610552738.599999
Debt to equity: 1.3709515401737313
Current ratio: 1.7590185475225943
Quick ratio: 1.7590185475225943
Effective tax rate (%): 52.85427423981641
Interest coverage ratio: 1.9348593491450634
COGS to revenue (%): 86.13669227623276
Free cash flow (dilution-adjusted): 24809000
Buyback yield (%): 0
Retained earnings: -95437000
Receivables turnover: 2.5725168968902206
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.1059650671542973
FCF margin (%): 4.529570285113344
Revenue growth (%): 4.7512856948872475
Rule of 40 score: 9.280855980000592
Financial ratios for RENX.L — annual report dated 2021-06-30
Capital expenditures: 1087500
Depreciation & amortization: 2851388.888888889
Buffett classification: The Gruesome
Stock price: 0.15000000000000002
Shares outstanding: 437018680
Market cap (USD): 65552802.00000001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RENX.L — annual report dated 2022-06-30
Total revenue: 3621951.2195121953
Gross profit: 1065853.6585365855
Operating income: -64857317.07317074
Net income: -55214634.146341465
Capital expenditures: 679268.2926829269
Operating cash flow: -56004878.04878049
Depreciation & amortization: 2748780.487804878
Net tangible assets: 37325609.75609756
Owner earnings: -53145121.951219514
Return on net tangible assets (%): -142.38246152840853
Buffett classification: The Gruesome
Stock price: 0.012804878048780489
Shares outstanding: 437018680
Book value: 37325609.75609757
P/B ratio: 0.14992309406344953
Market cap (USD): 5595970.902439025
Debt to equity: 0.4032410886398536
Current ratio: 3.800441576086956
Quick ratio: 3.7019361413043472
Interest coverage ratio: -26591.500000000004
COGS to revenue (%): 70.57239057239057
R&D to revenue (%): 493.19865319865323
SG&A to revenue (%): 1330.7744107744106
Free cash flow (dilution-adjusted): -62447560.97560976
Buyback yield (%): 0
Retained earnings: -161851219.51219514
Inventory turnover: 1.8068965517241378
Receivables turnover: 3.296337402885683
Capitalized R&D asset: 17863414.634146344
ROCI (R&D-adjusted, %): -82.01761842693516
FCF margin (%): -1724.1414141414139
Rule of 40 score: -1724.1414141414139
Financial ratios for RENX.L — annual report dated 2023-06-30
Total revenue: 4307594.936708861
Gross profit: 911392.4050632911
Operating income: -53444303.79746835
Net income: -57730379.74683544
Capital expenditures: 0
Operating cash flow: -43145569.62025316
Depreciation & amortization: 643037.9746835442
Net tangible assets: 8818987.341772152
Owner earnings: -57087341.772151895
Return on net tangible assets (%): -647.3230945887756
Buffett classification: The Gruesome
Stock price: 0.014303797468354428
Shares outstanding: 437018680
Book value: 8818987.34177215
P/B ratio: 0.7088145663843836
Market cap (USD): 6251026.688607594
Debt to equity: 1.7394861489880868
Current ratio: 1.665964303420922
Quick ratio: 1.665964303420922
COGS to revenue (%): 78.84219806053481
R&D to revenue (%): 420.15868351454594
SG&A to revenue (%): 842.2568322068761
Free cash flow (dilution-adjusted): -46856962.025316454
Buyback yield (%): 0
Retained earnings: -225727848.10126582
Receivables turnover: 4.385309278350515
Capitalized R&D asset: 30067221.982093237
ROCI (R&D-adjusted, %): -97.76951708581004
Rosenberg metric: -0.008646793271989446
FCF margin (%): -1087.7754922127533
Revenue growth (%): 18.9302305758002
Rule of 40 score: -1068.8452616369532
Financial ratios for RENX.L — annual report dated 2024-06-30
Total revenue: 2911392.405063291
Gross profit: 253164.5569620253
Operating income: -38607594.93670886
Net income: -57594936.708860755
Capital expenditures: 5063.291139240506
Operating cash flow: -37721518.98734177
Depreciation & amortization: 3164556.9620253164
Net tangible assets: -11392405.063291138
Owner earnings: -54435443.03797468
Buffett classification: The Gruesome
Stock price: 0.0013924050632911392
Shares outstanding: 437018680
Book value: -11392405.06329114
Market cap (USD): 608507.0227848102
Debt to equity: -0.9444444444444443
Current ratio: 0.576271186440678
Quick ratio: 0.5508474576271186
COGS to revenue (%): 91.30434782608695
R&D to revenue (%): 221.73913043478262
SG&A to revenue (%): 500
Free cash flow (dilution-adjusted): -39113924.05063291
Buyback yield (%): 0
Retained earnings: -183164556.9620253
Inventory turnover: 7
Receivables turnover: 3.2857142857142856
Capitalized R&D asset: 24476774.930534117
ROCI (R&D-adjusted, %): -249.85243915622402
Rosenberg metric: -0.036368722898307455
FCF margin (%): -1343.4782608695652
Revenue growth (%): -32.412577137819575
Rule of 40 score: -1375.890838007385
Financial ratios for RENX.L — quarterly report dated 2024-09-30
Total revenue: 696000
Gross profit: 133333.33333333334
Operating income: -5456000
Net income: -6304000
Capital expenditures: 0
Operating cash flow: -5114666.666666667
Depreciation & amortization: 80000
Net tangible assets: -15092000
Owner earnings: -6224000
Buffett classification: The Gruesome
Stock price: 0.0010666666666666667
Shares outstanding: 437018680
Book value: -15092000
Market cap (USD): 466153.2586666667
Debt to equity: -0.7291280148423006
Current ratio: 0.23965703820860731
Quick ratio: 0.23965703820860731
COGS to revenue (%): 80.84291187739463
R&D to revenue (%): 176.4367816091954
SG&A to revenue (%): 626.6283524904214
Free cash flow (dilution-adjusted): -5453333.333333334
Buyback yield (%): 0
Retained earnings: -288680000
Receivables turnover: 0.5787139689578713
Capitalized R&D asset: 1228000
FCF margin (%): -783.5249042145595
Rule of 40 score: -783.5249042145595
Financial ratios for RENX.L — quarterly report dated 2024-12-31
Total revenue: 911250
Gross profit: 497500
Operating income: -4245000
Net income: -4852500
Capital expenditures: 0
Operating cash flow: -8121250
Depreciation & amortization: -42500
Net tangible assets: -1711250
Owner earnings: -4895000
Buffett classification: The Gruesome
Stock price: 0.001375
Shares outstanding: 437018680
Book value: -1711250
Market cap (USD): 600900.6849999999
Debt to equity: -5.993425858290723
Current ratio: 2.429967426710098
Quick ratio: 2.339413680781759
COGS to revenue (%): 45.40466392318244
SG&A to revenue (%): -98.49108367626886
Free cash flow (dilution-adjusted): -8212500
Buyback yield (%): 0
Retained earnings: -191580000
Inventory turnover: 0.7937649880095923
Receivables turnover: 1.4294117647058824
Capitalized R&D asset: 822760
ROCI (R&D-adjusted, %): -49.684591976452566
Rosenberg metric: 0.29655266015200865
FCF margin (%): -901.2345679012345
Revenue growth (%): 30.926724137931032
Rule of 40 score: -870.3078437633035
Financial ratios for RENX.L — annual report dated 2025-06-30
Total revenue: 4109589.0410958906
Gross profit: 1643835.6164383562
Operating income: -23561643.83561644
Net income: -27945205.479452055
Capital expenditures: 0
Operating cash flow: -24520547.94520548
Depreciation & amortization: 0
Net tangible assets: -9589041.095890412
Owner earnings: -27945205.479452055
Buffett classification: The Gruesome
Stock price: 0.0009589041095890413
Shares outstanding: 437018680
Book value: -9589041.09589041
Market cap (USD): 419059.0082191782
Debt to equity: -1.1857142857142857
Current ratio: 1.2083333333333333
Quick ratio: 1.1666666666666665
Interest coverage ratio: -34.4
COGS to revenue (%): 60
R&D to revenue (%): 30
SG&A to revenue (%): 176.66666666666666
Free cash flow (dilution-adjusted): -28904109.589041095
Buyback yield (%): 0
Retained earnings: -226164383.56164384
Inventory turnover: 9
Receivables turnover: 5
Capitalized R&D asset: 11530775.446505982
ROCI (R&D-adjusted, %): -232.31273683864714
Rosenberg metric: 0.21541767391888264
FCF margin (%): -703.3333333333334
Revenue growth (%): 41.15544967242407
Rule of 40 score: -662.1778836609093
Financial ratios for RGN.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.413533834586466
Shares outstanding: 1148742322
Market cap (USD): 1623786139.368421
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RGN.AX — annual report dated 2022-06-30
Total revenue: 238896551.72413793
Gross profit: 157931034.4827586
Operating income: 139448275.86206898
Net income: 335931034.48275864
Capital expenditures: 0
Net tangible assets: 8000000
Owner earnings: 335931034.48275864
Return on net tangible assets (%): 4199.137931034484
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.4896551724137932
P/E ratio: 5.093991819995894
Shares outstanding: 1148742322
Book value: 2161310344.827586
P/B ratio: 0.7917557725262453
Market cap (USD): 1711229941.7379313
Debt to equity: 0.43919716646989376
Current ratio: 0.5695701357466063
Quick ratio: 0.5695701357466063
Effective tax rate (%): 0.08205128205128205
Interest coverage ratio: 5.632311977715878
COGS to revenue (%): 33.891454965357966
SG&A to revenue (%): 5.3983833718244805
Free cash flow (dilution-adjusted): 123724137.93103449
Buyback yield (%): 0.004030172425065079
Retained earnings: 965517.2413793104
Receivables turnover: 8
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.475233500066398
FCF margin (%): 51.789838337182445
Rule of 40 score: 51.789838337182445
Financial ratios for RGN.AX — annual report dated 2023-06-30
Total revenue: 241854304.6357616
Gross profit: 159337748.34437087
Operating income: 143708609.27152318
Net income: -81854304.63576159
Capital expenditures: 0
Net tangible assets: 8940397.350993378
Owner earnings: -81854304.63576159
Return on net tangible assets (%): -915.5555555555555
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.2516556291390728
Shares outstanding: 1148742322
Book value: 1939072847.6821191
P/B ratio: 0.7415037529303279
Market cap (USD): 1437829793.7615893
Debt to equity: 0.5202868852459016
Current ratio: 0.22505860901276376
Quick ratio: 0.22505860901276376
Interest coverage ratio: 4.419551934826884
COGS to revenue (%): 34.11829134720701
SG&A to revenue (%): 5.147864184008763
Free cash flow (dilution-adjusted): 117086092.71523179
Buyback yield (%): 0.00460591134293152
Retained earnings: 1788079.4701986755
Receivables turnover: 7.870689655172414
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.120218966046106
FCF margin (%): 48.411829134720705
Revenue growth (%): 1.238089411620757
Rule of 40 score: 49.64991854634146
Financial ratios for RGN.AX — annual report dated 2024-06-30
Total revenue: 250600000
Gross profit: 162266666.66666666
Operating income: 142933333.33333334
Net income: 11533333.333333334
Capital expenditures: 0
Net tangible assets: 9400000
Owner earnings: 11533333.333333334
Return on net tangible assets (%): 122.69503546099291
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.24
P/E ratio: 123.50639993757224
Shares outstanding: 1148742322
Book value: 1876333333.3333333
P/B ratio: 0.7591617406004619
Market cap (USD): 1424440479.28
Debt to equity: 0.5561911529578967
Current ratio: 1.0061349693251533
Quick ratio: 1.0061349693251533
Effective tax rate (%): 1.142857142857143
Interest coverage ratio: 3.3605015673981193
COGS to revenue (%): 35.2487363660548
SG&A to revenue (%): 4.362862463421123
Free cash flow (dilution-adjusted): 121866666.66666667
Buyback yield (%): 0.004680200235559447
Retained earnings: 2066666.6666666667
Receivables turnover: 17.81516587677725
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.8669753927176975
FCF margin (%): 48.62995477520617
Revenue growth (%): 3.6161007667031764
Rule of 40 score: 52.24605554190935
Financial ratios for SHIVAUM.NS — annual report dated 2022-03-31
Total revenue: 53649703.28366082
Gross profit: 4705472.76803376
Operating income: 3212712.6467097457
Net income: 1647276.8033759727
Capital expenditures: 128141.89634709219
Operating cash flow: 572385.5993670052
Depreciation & amortization: 81194.77779243044
Net tangible assets: 10739145.575629698
Owner earnings: 1600329.684821311
Return on net tangible assets (%): 14.901834354987542
Capex to operating income (%): 3.9885887858139726
Buffett classification: The Great
Stock price: 1.3187392852433075
P/E ratio: 10.887897976991987
Shares outstanding: 13600400
Book value: 10739145.575629698
P/B ratio: 1.6700939240197819
Market cap (USD): 17935381.77502308
Debt to equity: 0.5612611809484349
Current ratio: 2.835855161611196
Quick ratio: 1.204891211140711
Effective tax rate (%): 24.391838315850638
Interest coverage ratio: 5.899503571861
COGS to revenue (%): 91.22926599769877
SG&A to revenue (%): 0.5611739867958194
Free cash flow (dilution-adjusted): 442753.527627588
Buyback yield (%): 0
Retained earnings: 5876399.960437821
Inventory turnover: 5.203599043806826
Receivables turnover: 11.765517181544228
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 26.91808777935168
FCF margin (%): 0.8252674302533001
Rule of 40 score: 0.8252674302533001
Financial ratios for SHIVAUM.NS — annual report dated 2023-03-31
Total revenue: 60405237.515225336
Gross profit: 4486260.65773447
Operating income: 2889634.5919610234
Net income: 1744007.3081607798
Capital expenditures: 9378.806333739343
Operating cash flow: 778331.3032886724
Depreciation & amortization: 69890.37758830695
Net tangible assets: 11663008.526187576
Owner earnings: 1804518.8794153475
Return on net tangible assets (%): 15.47215605101861
Capex to operating income (%): 0.3245672085955513
Buffett classification: The Great
Stock price: 2.618757612667479
P/E ratio: 20.422019373808343
Shares outstanding: 13600400
Book value: 11663008.52618758
P/B ratio: 3.0537704705738595
Market cap (USD): 35616151.03532278
Debt to equity: 0.6148362510743753
Current ratio: 2.6400607754031884
Quick ratio: 1.1050012230877626
Effective tax rate (%): 26.01508810003617
Interest coverage ratio: 4.89576540509307
COGS to revenue (%): 92.57306014796532
SG&A to revenue (%): 0.44516632488249286
Free cash flow (dilution-adjusted): 768952.496954933
Buyback yield (%): 0
Retained earnings: 7171632.155907431
Inventory turnover: 5.152006679392525
Receivables turnover: 14.265287102397266
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 22.603382518414627
FCF margin (%): 1.272989774704745
Revenue growth (%): 12.591932141443795
Rule of 40 score: 13.86492191614854
Financial ratios for SHIVAUM.NS — annual report dated 2024-03-31
Total revenue: 66521213.574769154
Gross profit: 3724883.079505936
Operating income: 2394064.0364552103
Net income: 1254251.1092457129
Capital expenditures: 84290.68233601151
Operating cash flow: 1278222.8084902267
Depreciation & amortization: 64636.047487708354
Net tangible assets: 12723995.682935603
Owner earnings: 1234596.4743974097
Return on net tangible assets (%): 9.702899192689534
Capex to operating income (%): 3.520819871669647
Buffett classification: The Great
Stock price: 3.742802303262956
P/E ratio: 40.58486220985696
Shares outstanding: 13600400
Book value: 12736826.957668783
P/B ratio: 3.996569052439602
Market cap (USD): 50903608.4452975
Debt to equity: 0.6510501598683394
Current ratio: 2.552672562515824
Quick ratio: 1.2560175344595113
Effective tax rate (%): 25.48003961440083
Interest coverage ratio: 3.066823355915019
COGS to revenue (%): 94.40045832098477
SG&A to revenue (%): 0.2609422692945852
Free cash flow (dilution-adjusted): 1186737.0188271976
Buyback yield (%): 0
Retained earnings: 8314929.847703561
Inventory turnover: 5.944721187903006
Receivables turnover: 9.579273473278487
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.29310998965745
FCF margin (%): 1.7839978482853707
Revenue growth (%): 10.12491020832799
Rule of 40 score: 11.90890805661336
Financial ratios for SHIVAUM.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 13545950.788342092
Buffett classification: The Gruesome
Stock price: 3.511705685618729
Shares outstanding: 13600400
Book value: 13558731.485905398
P/B ratio: 3.5224978130393074
Market cap (USD): 47760602.00668896
Debt to equity: 0.6574704198700245
Current ratio: 2.585639842464947
Quick ratio: 1.0919442551432896
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SHIVAUM.NS — quarterly report dated 2025-03-31
Total revenue: 17899181.669394433
Gross profit: 1063806.4063595978
Operating income: 568038.3446340893
Net income: 230301.61328033666
Capital expenditures: 0
Depreciation & amortization: 19324.292728548047
Net tangible assets: 13546223.98877718
Owner earnings: 249625.90600888472
Return on net tangible assets (%): 1.8427711384050316
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.9174932897654338
P/E ratio: 43.072945921818295
Shares outstanding: 13600400
Book value: 13558732.756605096
P/B ratio: 2.926459017255596
Market cap (USD): 39679075.73812581
Debt to equity: 0.8128251598963281
Current ratio: 2.4114734160949083
Quick ratio: 1.1358911402280916
Effective tax rate (%): 27.56655390498603
Interest coverage ratio: 1.7850189192167811
COGS to revenue (%): 94.05667574077654
Buyback yield (%): 0
Retained earnings: 9247977.554360533
Inventory turnover: 1.2953177450052709
Receivables turnover: 2.572954914775162
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.747054178439671
Rule of 40 score: 0
Financial ratios for SHIVAUM.NS — annual report dated 2025-03-31
Total revenue: 64898269.815291084
Gross profit: 3107937.8068739767
Operating income: 1709410.8019639933
Net income: 1036789.805938742
Capital expenditures: 27601.122281973345
Operating cash flow: 796036.9417816226
Depreciation & amortization: 65828.85199906476
Net tangible assets: 13546223.98877718
Owner earnings: 1075017.5356558335
Return on net tangible assets (%): 7.9359202722948305
Capex to operating income (%): 1.6146570648940317
Buffett classification: The Great
Stock price: 2.9174932897654338
P/E ratio: 38.27108977233734
Shares outstanding: 13600400
Book value: 13558732.756605096
P/B ratio: 2.926459017255596
Market cap (USD): 39679075.73812581
Debt to equity: 0.8128251598963281
Current ratio: 2.4114734160949083
Quick ratio: 1.1358911402280916
Effective tax rate (%): 24.372377801275714
Interest coverage ratio: 1.8299605781865966
COGS to revenue (%): 95.21106215047092
SG&A to revenue (%): 0.24078619475670815
Free cash flow (dilution-adjusted): 768435.8194996492
Buyback yield (%): 0
Retained earnings: 9247977.554360533
Inventory turnover: 4.754162724011758
Receivables turnover: 9.328936113720502
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.276095969005638
FCF margin (%): 1.1840621047166857
Revenue growth (%): -2.439738652172811
Rule of 40 score: -1.2556765474561253
Financial ratios for SHIVAUM.NS — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 13353979.706877114
Buffett classification: The Gruesome
Stock price: 3.3483652762119505
Shares outstanding: 13600400
Book value: 13366042.841037203
P/B ratio: 3.4070747523549896
Market cap (USD): 45539107.10259301
Debt to equity: 0.6323053591190045
Current ratio: 2.856496275404273
Quick ratio: 1.418052196432425
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SOPH — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 14.1
Shares outstanding: 83895266
Market cap (USD): 1182923250.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SOPH — annual report dated 2022-12-31
Total revenue: 51695652.17391304
Gross profit: 33971739.13043478
Operating income: -95459782.60869564
Net income: -95053260.86956522
Capital expenditures: 4453260.869565217
Operating cash flow: -76188043.47826086
Depreciation & amortization: 6055434.782608695
Net tangible assets: 195833695.6521739
Owner earnings: -93451086.95652175
Return on net tangible assets (%): -47.719615689887725
Buffett classification: The Gruesome
Stock price: 2.06
Shares outstanding: 83895266
Book value: 217532608.69565216
P/B ratio: 0.7944751317803429
Market cap (USD): 172824247.96
Debt to equity: 0.08366062059661221
Current ratio: 7.320216337187617
Quick ratio: 7.126445356210369
Interest coverage ratio: -137.43818466353676
COGS to revenue (%): 34.28511354079058
R&D to revenue (%): 74.3713204373423
SG&A to revenue (%): 176.79352396972246
Free cash flow (dilution-adjusted): -102268478.26086956
Buyback yield (%): 0
Retained earnings: -324785869.5652174
Inventory turnover: 3.13878729547642
Receivables turnover: 5.905873587482925
Capitalized R&D asset: 38446739.13043478
ROCI (R&D-adjusted, %): -25.4526893265557
FCF margin (%): -197.82800672834315
Rule of 40 score: -197.82800672834315
Financial ratios for SOPH — annual report dated 2023-12-31
Total revenue: 74251190.47619048
Gross profit: 51086904.76190476
Operating income: -89078571.42857143
Net income: -94025000
Capital expenditures: 1778571.4285714286
Operating cash flow: -63361904.76190476
Depreciation & amortization: 9923809.523809524
Net tangible assets: 147925000
Owner earnings: -85879761.90476191
Return on net tangible assets (%): -58.05628656735637
Buffett classification: The Gruesome
Stock price: 4.71
Shares outstanding: 83895266
Book value: 180288095.23809522
P/B ratio: 2.1917514982792095
Market cap (USD): 395146702.86
Debt to equity: 0.12282590034468642
Current ratio: 4.156171921057803
Quick ratio: 3.9594621150444964
Interest coverage ratio: -127.25510204081634
COGS to revenue (%): 31.197191002228603
R&D to revenue (%): 59.272738933158045
SG&A to revenue (%): 125.02765708422183
Free cash flow (dilution-adjusted): -92490476.19047621
Buyback yield (%): 0
Retained earnings: -449742857.14285713
Inventory turnover: 2.77693734836592
Receivables turnover: 4.102005919105557
Capitalized R&D asset: 69770029.5031056
ROCI (R&D-adjusted, %): -26.597102914032185
Rosenberg metric: 0.4451655983984728
FCF margin (%): -124.56430071667926
Revenue growth (%): 43.63140293964518
Rule of 40 score: -80.93289777703407
Financial ratios for SOPH — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.65
Shares outstanding: 83895266
Market cap (USD): 306217720.9
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SOPH — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.07
Shares outstanding: 83895266
Market cap (USD): 257558466.61999997
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SOPH — annual report dated 2024-12-31
Total revenue: 72414444.44444445
Gross profit: 48818888.88888889
Operating income: -73964444.44444445
Net income: -69436666.66666667
Capital expenditures: 271111.1111111111
Operating cash flow: -49461111.11111111
Depreciation & amortization: 9551111.11111111
Net tangible assets: 74991111.1111111
Owner earnings: -60156666.66666667
Return on net tangible assets (%): -80.2183962543709
Buffett classification: The Gruesome
Stock price: 3.07
Shares outstanding: 83895266
Book value: 107211111.1111111
P/B ratio: 2.402348636729195
Market cap (USD): 257558466.61999997
Debt to equity: 0.3112239610322313
Current ratio: 3.708726635078163
Quick ratio: 3.489795918367347
Interest coverage ratio: -34.79769994772609
COGS to revenue (%): 32.58404554033112
R&D to revenue (%): 52.730425176069836
SG&A to revenue (%): 112.33332821874089
Free cash flow (dilution-adjusted): -76865555.55555555
Buyback yield (%): 0
Retained earnings: -489196666.6666666
Inventory turnover: 3.6189502385821406
Receivables turnover: 7.499769850402762
Capitalized R&D asset: 80359046.9289165
ROCI (R&D-adjusted, %): -34.05609793313622
Rosenberg metric: -0.05153326661076397
FCF margin (%): -106.14671719884
Revenue growth (%): -2.473692367713625
Rule of 40 score: -108.62040956655362
Financial ratios for SOPH — quarterly report dated 2025-03-31
Total revenue: 20203409.09090909
Gross profit: 13872727.272727273
Operating income: -18222727.272727273
Net income: -19755681.818181816
Capital expenditures: 0
Operating cash flow: -12215909.090909092
Depreciation & amortization: 2610227.272727273
Net tangible assets: 63203409.09090909
Owner earnings: -17145454.545454543
Return on net tangible assets (%): -27.127420485805203
Buffett classification: The Gruesome
Stock price: 3.32
Shares outstanding: 83895266
Book value: 97287500.00000001
P/B ratio: 2.8629811961454448
Market cap (USD): 278532283.12
Debt to equity: 0.35193253361054977
Current ratio: 3.111214759535655
Quick ratio: 2.9367399115533446
Interest coverage ratio: -24.333839150227618
COGS to revenue (%): 31.33472073794927
R&D to revenue (%): 51.28522414084033
SG&A to revenue (%): 107.62135103211654
Free cash flow (dilution-adjusted): -18268181.81818182
Buyback yield (%): 0
Retained earnings: -520070454.54545456
Inventory turnover: 1.1031683168316833
Receivables turnover: 1.6623655913978492
Capitalized R&D asset: 10361363.636363637
ROCI (R&D-adjusted, %): -7.847031225783403
FCF margin (%): -90.42128353675686
Rule of 40 score: -90.42128353675686
Financial ratios for SOPH — quarterly report dated 2025-06-30
Total revenue: 22903750
Gross profit: 15337500
Operating income: -23115000
Net income: -28017500
Capital expenditures: 162500
Operating cash flow: -10267500
Depreciation & amortization: 2962500
Net tangible assets: 53702500
Owner earnings: -25217500
Return on net tangible assets (%): -46.95777663982123
Buffett classification: The Gruesome
Stock price: 3.1
Shares outstanding: 83895266
Book value: 95865000
P/B ratio: 2.712933026652063
Market cap (USD): 260075324.6
Debt to equity: 0.8320685338757627
Current ratio: 3.3937654052486588
Quick ratio: 3.21348412353197
Interest coverage ratio: -33.08050089445438
COGS to revenue (%): 33.034983354254216
R&D to revenue (%): 46.35157998144408
SG&A to revenue (%): 121.89597773290399
Free cash flow (dilution-adjusted): -18182500
Buyback yield (%): 0
Retained earnings: -600095000
Inventory turnover: 0.9736207173878076
Receivables turnover: 1.927722251446607
Capitalized R&D asset: 17558363.636363637
ROCI (R&D-adjusted, %): -9.920385900447423
Rosenberg metric: 0.14136872121079178
FCF margin (%): -79.3865633356983
Revenue growth (%): 13.36576860340852
Rule of 40 score: -66.02079473228977
Financial ratios for SOPH — quarterly report dated 2025-09-30
Total revenue: 24327500
Gross profit: 16133750
Operating income: -22327500
Net income: -25026250
Capital expenditures: 132500
Operating cash flow: -10991250
Depreciation & amortization: 3030000
Net tangible assets: 32507500
Owner earnings: -22128750
Return on net tangible assets (%): -68.07275244174421
Buffett classification: The Gruesome
Stock price: 4.76
Shares outstanding: 83895266
Book value: 75858750
P/B ratio: 5.264276911496696
Market cap (USD): 399341466.15999997
Debt to equity: 1.0442598909156822
Current ratio: 2.802285590489344
Quick ratio: 2.621388144176348
Interest coverage ratio: -10.740829825616355
COGS to revenue (%): 33.68101942246429
R&D to revenue (%): 41.45000513821807
SG&A to revenue (%): 115.91306135032372
Free cash flow (dilution-adjusted): -19535000
Buyback yield (%): 0
Retained earnings: -625121250
Inventory turnover: 0.9812874251497006
Receivables turnover: 2.301833234772324
Capitalized R&D asset: 20615887.5
ROCI (R&D-adjusted, %): -12.639883487171675
Rosenberg metric: 0.07500294360061227
FCF margin (%): -80.30007193505291
Revenue growth (%): 6.21623096654478
Rule of 40 score: -74.08384096850813
Financial ratios for SOPH — quarterly report dated 2025-12-31
Total revenue: 27477215.189873416
Gross profit: 18597468.354430377
Operating income: -23437974.683544304
Net income: -24277215.189873416
Capital expenditures: 427848.10126582277
Operating cash flow: -10298734.177215189
Depreciation & amortization: 3086075.9493670883
Net tangible assets: 14245569.620253164
Owner earnings: -21618987.34177215
Return on net tangible assets (%): -151.75937444464188
Buffett classification: The Gruesome
Stock price: 4.67
Shares outstanding: 83895266
Book value: 59677215.18987343
P/B ratio: 6.565167140816628
Market cap (USD): 391790892.21999997
Debt to equity: 1.336727118464312
Current ratio: 1.9608731792273593
Quick ratio: 1.835180493983534
Interest coverage ratio: -11.067543335325762
COGS to revenue (%): 32.31676417745428
R&D to revenue (%): 39.33293407656516
SG&A to revenue (%): 101.52946054268209
Free cash flow (dilution-adjusted): -18313924.05063291
Buyback yield (%): 0
Retained earnings: -657311392.4050633
Inventory turnover: 1.1045504644937807
Receivables turnover: 1.313585476550681
Capitalized R&D asset: 21067069.93670886
ROCI (R&D-adjusted, %): -14.150652817138191
Rosenberg metric: 0.24432560847208404
FCF margin (%): -66.65131063712167
Revenue growth (%): 12.947138793026063
Rule of 40 score: -53.704171844095605
Financial ratios for SOPH — annual report dated 2025-12-31
Total revenue: 97811392.40506329
Gross profit: 65920253.16455696
Operating income: -89754430.37974682
Net income: -99998734.17721519
Capital expenditures: 726582.2784810127
Operating cash flow: -45434177.215189874
Depreciation & amortization: 12062025.316455696
Net tangible assets: 14245569.620253164
Owner earnings: -88663291.1392405
Return on net tangible assets (%): -622.3920383863515
Buffett classification: The Gruesome
Stock price: 4.67
Shares outstanding: 83895266
Book value: 59677215.18987343
P/B ratio: 6.565167140816628
Market cap (USD): 391790892.21999997
Debt to equity: 1.336727118464312
Current ratio: 1.9608731792273593
Quick ratio: 1.835180493983534
Interest coverage ratio: -15.570048309178743
COGS to revenue (%): 32.6047288115852
R&D to revenue (%): 44.280519211605906
SG&A to revenue (%): 111.38331327406141
Free cash flow (dilution-adjusted): -76858227.84810126
Buyback yield (%): 0
Retained earnings: -657311392.4050633
Inventory turnover: 3.966934341048654
Receivables turnover: 4.676006051437216
Capitalized R&D asset: 83418505.89712678
ROCI (R&D-adjusted, %): -39.09116788045827
Rosenberg metric: 0.44786206855907773
FCF margin (%): -78.57799174334484
Revenue growth (%): 35.07166029576198
Rule of 40 score: -43.50633144758286
Financial ratios for SRZ.AX — annual report dated 2021-06-30
Operating income: -544980.4511278195
Net income: -541713.5338345864
Capital expenditures: 1618.796992481203
Depreciation & amortization: 8612.781954887218
Net tangible assets: 12675605.263157895
Owner earnings: -534719.5488721804
Return on net tangible assets (%): -4.218493221987293
Buffett classification: The Gruesome
Stock price: 0.18796992481203006
Shares outstanding: 339149219
Book value: 12848694.736842103
P/B ratio: 4.961582051809014
Market cap (USD): 63749853.19548872
Debt to equity: 0.00034408573961229735
Current ratio: 23.79374636189086
Quick ratio: 23.79374636189086
Interest coverage ratio: -1902.4251968503936
Free cash flow (dilution-adjusted): -672839.0977443609
Buyback yield (%): 0.4564433332809768
Retained earnings: -19671545.112781953
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.2410825824014236
Rule of 40 score: 0
Financial ratios for SRZ.AX — annual report dated 2022-06-30
Operating income: -631550.3448275862
Net income: -504955.8620689655
Capital expenditures: 49687.58620689655
Depreciation & amortization: 4318.620689655172
Net tangible assets: 11493423.448275862
Owner earnings: -550324.8275862068
Return on net tangible assets (%): -4.788171514456482
Buffett classification: The Gruesome
Stock price: 0.10344827586206896
Shares outstanding: 339149219
Book value: 11674595.862068966
P/B ratio: 3.0051919895152244
Market cap (USD): 35084401.96551724
Debt to equity: 0.002599573113776544
Current ratio: 8.128843237711312
Quick ratio: 8.128843237711312
Interest coverage ratio: -2766.6102719033233
Free cash flow (dilution-adjusted): -2383166.896551724
Buyback yield (%): 0.004914257716945139
Retained earnings: -18202583.448275864
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.400022065986025
Rule of 40 score: 0
Financial ratios for SRZ.AX — annual report dated 2023-06-30
Operating income: -2271832.450331126
Net income: -2206894.0397350993
Capital expenditures: 305.96026490066225
Depreciation & amortization: 26554.966887417217
Net tangible assets: 1154543.7086092716
Owner earnings: -2180645.0331125828
Return on net tangible assets (%): -188.87505226972496
Buffett classification: The Gruesome
Stock price: 0.08609271523178808
Shares outstanding: 339149219
Book value: 1328517.2185430464
P/B ratio: 21.97809461925634
Market cap (USD): 29198277.13245033
Debt to equity: 0.012545979409399815
Current ratio: 5.151239782059532
Quick ratio: 5.151239782059532
Interest coverage ratio: -956.894560669456
Free cash flow (dilution-adjusted): -2115315.894039735
Buyback yield (%): 0.40352557797098926
Retained earnings: -28878656.953642383
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -169.67247777617857
Rule of 40 score: 0
Financial ratios for SRZ.AX — annual report dated 2024-06-30
Operating income: -1571290
Net income: -1500754.6666666667
Capital expenditures: 0
Depreciation & amortization: 26674.666666666668
Net tangible assets: 7105819.333333333
Owner earnings: -1474080
Return on net tangible assets (%): -20.744687288700185
Buffett classification: The Gruesome
Stock price: 0.13333333333333333
Shares outstanding: 339149219
Book value: 7290368.666666667
P/B ratio: 6.202689868541627
Market cap (USD): 45219895.86666667
Debt to equity: 0.0014088907986637713
Current ratio: 43.28033777120316
Quick ratio: 43.28033777120316
Interest coverage ratio: -1970.6814381270901
Free cash flow (dilution-adjusted): -1537535.3333333333
Buyback yield (%): 1.1283263488806679
Retained earnings: -30571936
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -21.53742923726796
Rule of 40 score: 0
Financial ratios for TORQ.V — annual report dated 2021-12-31
Operating income: -5049114.173228347
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.6456692913385826
Shares outstanding: 185897146
Market cap (USD): 120028078.51968503
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TORQ.V — annual report dated 2022-12-31
Total revenue: 0
Operating income: -8749668.38235294
Net income: -8617166.176470587
Capital expenditures: 925009.5588235294
Operating cash flow: -7423373.529411764
Depreciation & amortization: 133566.17647058822
Net tangible assets: 8824619.852941176
Owner earnings: -9408609.558823528
Return on net tangible assets (%): -106.61773215860073
Buffett classification: The Gruesome
Stock price: 0.5367647058823529
Shares outstanding: 185897146
Book value: 8824619.852941176
P/B ratio: 11.307345648866896
Market cap (USD): 99783026.89705881
Debt to equity: 0.16387224812133633
Current ratio: 7.940232701149459
Quick ratio: 7.940232701149459
Interest coverage ratio: -67.05973614656772
Free cash flow (dilution-adjusted): -8709338.235294117
Buyback yield (%): 0
Retained earnings: -49166558.82352941
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -85.19032490458859
Rule of 40 score: 0
Financial ratios for TORQ.V — annual report dated 2023-12-31
Total revenue: 0
Operating income: -14167587.121212121
Net income: -14554272.727272727
Capital expenditures: 656490.1515151515
Operating cash flow: -12652302.272727272
Depreciation & amortization: 214298.48484848483
Net tangible assets: 786309.0909090908
Owner earnings: -14996464.393939395
Return on net tangible assets (%): -1907.1971273537279
Buffett classification: The Gruesome
Stock price: 0.16666666666666666
Shares outstanding: 185897146
Book value: 786309.0909090908
P/B ratio: 39.40289896794383
Market cap (USD): 30982857.666666664
Debt to equity: 1.8971807292991425
Current ratio: 0.9042145753647678
Quick ratio: 0.9042145753647678
Interest coverage ratio: -34.45018679261967
Free cash flow (dilution-adjusted): -14963775.757575758
Buyback yield (%): 0
Retained earnings: -65209373.484848484
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -621.9092370800099
Rule of 40 score: 0
Financial ratios for TORQ.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.08148148148148147
Shares outstanding: 185897146
Market cap (USD): 15147174.859259257
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0